Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
SUM225CWN
HER2amp
Basal A
Sirolimus
MTOR
MTOR
7534.069
uM
0.01858
1.36910
-0.8119 -1.0000 0.2555 0.6545
0.7962
0.8641
SUM225CWN
HER2amp
Basal A
Sirolimus
MTOR
MTOR
7533.069
uM
0.00404
0.00166
0.2934 0.3132 1.1071 0.5248
0.9943
1.1713
SUM225CWN
HER2amp
Basal A
Sorafenib
PDGFR/VEGFR/KIT/FLT3
RTK
7534.084
uM
10.43950
104.81120
-0.8432 -1.0000 0.4763 0.4154
0.8179
0.8905
SUM225CWN
HER2amp
Basal A
Sorafenib
PDGFR/VEGFR/KIT/FLT3
RTK
7533.084
uM
62.5130
235.27250
-0.1872 -0.6522 0.6299 0.2496
0.9859
1.0396
SUM225CWN
HER2amp
Basal A
Sulindac sulfide
COX1/2
COX
10579.136
uM
inf
inf
1.0500 1.0500 0.0000 -0.0370
-2.7510
0.6876
SUM225CWN
HER2amp
Basal A
Sunitinib
PDGFR/VEGFR/KIT/FLT3
RTK
7534.067
uM
5.05080
7.3920
-0.9982 -1.0000 2.8847 0.4927
0.9968
1.1276
SUM225CWN
HER2amp
Basal A
Sunitinib
PDGFR/VEGFR/KIT/FLT3
RTK
7533.067
uM
7.49230
10.23850
-0.9978 -0.9990 3.5158 0.3989
0.9982
1.0554
SUM225CWN
HER2amp
Basal A
TCS 2312
CHK1
CHK
12098.159
uM
0.68326
0.91431
-0.5733 -0.4456 2.1874 0.3698
0.9871
1.0261
SUM225CWN
HER2amp
Basal A
TCS 2312
CHK1
CHK
10579.14
uM
0.89562
1.64720
-0.6237 -0.6332 1.3428 0.3766
0.9973
0.9303
SUM225CWN
HER2amp
Basal A
TCS PIM-1 1
Pim kinase
PIM
12098.135
uM
46.02120
26.01180
0.4713 0.4711 4.9981 0.0756
0.8364
1.2823
SUM225CWN
HER2amp
Basal A
TCS PIM-1 1
Pim kinase
PIM
10579.135
uM
27.94260
27.10220
0.0711 0.0708 5.0000 0.0993
0.9788
0.7853
SUM225CWN
HER2amp
Basal A
Temsirolimus
MTOR
MTOR
10579.144
uM
inf
inf
-0.9866 -0.9866 0.0000 0.8900
0.5669
0.9576
SUM225CWN
HER2amp
Basal A
Temsirolimus
MTOR
MTOR
12098.144
uM
0.05398
1.60770
-0.9617 -1.0000 0.3237 0.7616
0.8855
1.1959
SUM225CWN
HER2amp
Basal A
Torkinib
15403.211
uM
0.02304
0.20245
-0.6514 -0.8008 0.4399 0.7911
0.9881
0.7553
SUM225CWN
HER2amp
Basal A
Tozasertib
AURK/FLT3/ABL/JAK2
AURK
12098.16
uM
14.87220
31.06620
-0.0609 -1.0000 1.4914 0.1300
0.9038
0.9575
SUM225CWN
HER2amp
Basal A
Tozasertib
AURK/FLT3/ABL/JAK2
AURK
10579.138
uM
17.78210
27.86030
-0.9296 -1.0000 2.4468 0.2690
0.9743
0.9860
SUM225CWN
HER2amp
Basal A
TPCA-1
IKK
NFKB
10579.1
uM
55.67060
355.420
0.2212 -1.0000 0.5926 0.1641
0.7025
0.9677
SUM225CWN
HER2amp
Basal A
Trichostatin A
HDAC
HDAC
7533.065
uM
15.79290
30.37820
-0.8989 -0.9229 1.5987 0.7929
0.9958
1.0679
SUM225CWN
HER2amp
Basal A
Trichostatin A
HDAC
HDAC
7534.065
uM
10.50870
15.19020
-0.9528 -0.9489 2.8877 0.8542
0.9991
0.9529
SUM225CWN
HER2amp
Basal A
Triciribine
AKT
AKT
7534.074
uM
0.13095
1.40330
-0.2458 -0.6053 0.3345 0.4788
0.9547
1.1026
SUM225CWN
HER2amp
Basal A
Triciribine
AKT
AKT
7533.074
uM
0.12897
0.47437
-0.1958 -0.3392 0.3976 0.4636
0.9657
1.0648
SUM225CWN
HER2amp
Basal A
Valproic acid
HDAC
HDAC
12098.143
uM
662.97740
1000.00000
-0.9490 -0.4767 1.6290 0.2498
0.8247
0.9820
SUM225CWN
HER2amp
Basal A
Valproic acid
HDAC
HDAC
10579.143
uM
578.370
1000.00000
-0.9691 -0.5846 1.4142 0.2789
0.8858
0.7678
SUM225CWN
HER2amp
Basal A
Vorinostat
HDAC
HDAC
7534.065
uM
154.18940
274.48430
-0.9415 -0.9448 1.8400 0.6487
0.9875
0.9529
SUM225CWN
HER2amp
Basal A
Vorinostat
HDAC
HDAC
7533.065
uM
128.55160
280.87380
-0.8907 -0.9190 1.3346 0.6680
0.9918
1.0679